Understanding the therapeutic uses of cannabinoids in pain and symptoms management
Apr 23, 2009
Dr. Mark A. Ware MBBS MRCP(UK) MSc

Executive Director
Canadian Consortium for the Investigation of Cannabinoids

Assistant Professor, Anesthesia/Family Medicine
MUHC Pain Centre
McGill

Dr. Ware will be joining the forum. For section 1 accreditation you must interact on the forum.

Title:

Understanding the therapeutic uses of cannabinoids in pain and symptoms management

Description

A discussion of the basic concepts of cannabinoid neurophysiology, the clinical trial evidence of cannabinoids in chronic disease management, the assess the risks and benefits of existing pharmaceutical cannabinoid preparations
and the attitudes towards the use of cannabis and cannabinoids in clinical practice.

Keywords

pain, McGill, cannabinoids, marijuana, THC, Cannabidio, Nabilone, Anandamide, CB1, CB2

Category(ies)

Pain/Douleur; Anesthesia/Anesthesia; Pharmacology/Pharmacologie; CCIC; Inhalation Therapy/Inhalothérapie;

Accredited/Certified (1)
You must login to view this conference
 
REGISTER NOW As New User
ACCESS As Returning User

 

From Montreal, QC, Canada
Copyright © 2002-2017 Continuing Professional Development (CPD) Office,
Faculty of Medicine, McGill University